Latanoprost (0.005%)

Optic Nerve Head Strain in Non-glaucoma Subjects

Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital

MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Effect of Latanoprost on Optic Nerve Perfusion

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Nailfold Capillary Blood Flow With Latanoprost Bunod

Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

A Study of Glaucoma or Ocular Hypertension in Patients Within the United States

A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects

AL-54478 Proof of Concept Study

AR-12286 in Combination With Latanoprost

Relationship Between Eye Pressure and Ganglion Cell Function in Eyes Receiving Latanoprost Versus Placebo

Effect of Age on Latanoprost 0.005% in Patients With Glaucoma

An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Latanoprost Versus Fotil

Cosopt Versus Xalatan